European healthcare products maker Greiner Bio-One International has begun work on a new project to double the operating area of its key plant at Mosonmagyaróvár in north western Hungary.
On March 22, the firm, part of the Kremsmünster, Austria-based foam and plastics processor Greiner Group, laid the foundation cornerstone for the site’s latest extension. From autumn this year, Greiner will start the manufacture of moulded plastic laboratory products at the expanded plant.
This project is set to grow the existing unit by 2,000m2 taking the total production area to 4,000m2.
Greiner Bio-One completed work on a previous €7.4m expansion scheme in Mosonmagyaróvár to create the present facility with the creation of 40 jobs in 2015. This initiative allowed Greiner Bio-One Hungary Kft. to boost productivity as well as introduce a special extrusion process to mould medical pipettes in Hungary.
The northern Hungarian site is located close to the Austrian border and serves Greiner Bio-One’s main businesses including the firm’s Preanalytics, Bioscience and Diagnostics divisions.
The company’s latest project has confirmed Greiner’s announced growth strategy. “It is investments in Hungary and Brazil, as well as the many innovations that ensure the further development of Greiner Bio-One,” stressed Rainer Perneker, Greiner Bio-One International’s chief executive recently.
Meanwhile, the group’s healthcare subsidiary has consolidated its presence in Iberia with the acquisition of its long time local distribution partners, Vacuette España S.A. and Vacuette Portugal Importação e Exportação de Material Hospitalar, S.A.
The takeover, which took effect at the start of March, means regional customers will now be served directly by Bio-One’s own centres in Madrid and Porto.
“Following the establishment of our own distribution subsidiaries in Turkey and Italy last year, the new Greiner Bio-One sites in Spain and Portugal are the next step in systematic implementation of our distribution strategy in Europe,” explained CEO Rainer Perneker.
“By attaining greater proximity to customers, we aim to develop the two markets on the Iberian Peninsula in an even more targeted way,” added Manfred Buchberger, managing director of Greiner Bio-One’s Preanalytics business.